LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025
LeMaitre Vascular (LMAT) has scheduled its Q4 2024 earnings release for Thursday, February 27, 2025, after market close. The company will host a conference call at 5:00 PM EST on the same day to discuss financial results, business highlights, and company outlook. Interested parties can access the live call by registering online, and all registrants will receive dial-in information and a PIN. Additionally, an audio webcast will be available live and for replay through the company's investor relations website.
LeMaitre Vascular (LMAT) ha programmato il suo rilascio dei risultati finanziari del Q4 2024 per giovedì 27 febbraio 2025, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica alle 17:00 EST nello stesso giorno per discutere i risultati finanziari, i punti salienti dell'azienda e le prospettive future. Le parti interessate possono accedere alla chiamata dal vivo registrandosi online, e tutti i registrati riceveranno informazioni per la chiamata e un PIN. Inoltre, un webcast audio sarà disponibile sia in diretta che per la visione successiva sul sito web delle relazioni con gli investitori dell'azienda.
LeMaitre Vascular (LMAT) ha programado su publicación de resultados del cuarto trimestre de 2024 para el jueves 27 de febrero de 2025, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica a las 5:00 PM EST el mismo día para discutir los resultados financieros, los aspectos destacados del negocio y las perspectivas de la compañía. Las partes interesadas pueden acceder a la llamada en vivo registrándose en línea, y todos los registrados recibirán información para la llamada y un PIN. Además, se disponibilizará una transmisión de audio en vivo y para repetición a través del sitio web de relaciones con los inversores de la empresa.
LeMaitre Vascular (LMAT)는 2025년 2월 27일 목요일, 시장 폐장 후 2024년 4분기 실적 발표를 예정하고 있습니다. 같은 날 오후 5시 EST에 재무 성과, 사업 주요 사항 및 회사 전망에 대해 논의하기 위한 전화 회의를 개최할 예정입니다. 관심이 있는 사람들은 온라인에서 등록하여 실시간 전화를 이용할 수 있으며, 모든 등록자는 전화 접속 정보와 PIN을 받을 것입니다. 또한, 회사의 투자자 관계 웹사이트를 통해 오디오 웹캐스트가 실시간 및 재생으로 제공될 것입니다.
LeMaitre Vascular (LMAT) a programmé la publication de ses résultats pour le quatrième trimestre de 2024 pour le jeudi 27 février 2025, après la fermeture du marché. L'entreprise animera une conférence téléphonique à 17h00 EST le même jour pour discuter des résultats financiers, des points forts de l'entreprise et des perspectives futures. Les parties intéressées peuvent accéder à la conférence en direct en s'inscrivant en ligne, et tous les inscrits recevront des informations pour se connecter et un code PIN. De plus, un webcast audio sera disponible en direct et en replay via le site des relations investisseurs de l'entreprise.
LeMaitre Vascular (LMAT) hat die Veröffentlichung der Quartalsergebnisse Q4 2024 für Donnerstag, den 27. Februar 2025, nach Börsenschluss anberaumt. Das Unternehmen wird am selben Tag um 17:00 Uhr EST eine Telefonkonferenz abhalten, um die finanziellen Ergebnisse, geschäftliche Highlights und die Unternehmensausblicke zu diskutieren. Interessierte Parteien können den Live-Anruf durch eine Online-Registrierung zugänglich machen, und alle Registrierten erhalten Informationen zur Einwahl und eine PIN. Darüber hinaus wird ein Audio-Webcast live und zur Wiederholung über die Investor Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
BURLINGTON, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2024 financial results on Thursday, February 27, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook.
Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay through a webcast at www.lemaitre.com/investor.
About LeMaitre
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.
FAQ
When will LMAT release Q4 2024 earnings?
What time is LeMaitre's Q4 2024 earnings call?
How can investors access LMAT's Q4 2024 earnings call?
Will LMAT's Q4 2024 earnings call be available for replay?
